Cadrenal Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage
Cadrenal Therapeutics, Inc. (CVKD) had Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage of 33.33% as of 2022-10-03, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage · last filed 2023-03-30
- 2022-10-03: Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 33.33%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage |
|---|---|
| 2022-10-03 | 33.33% 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |